The Claude D. Pepper Older Americans Independence Centers
12
2
4
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
8.3%
1 terminated/withdrawn out of 12 trials
85.7%
-0.8% vs industry average
8%
1 trials in Phase 3/4
67%
4 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Preserving Ability Through Virtual Exercise (PAVE)
Role: collaborator
Walking Sensation Study
Role: collaborator
Muscle Impact of Treating Osteoporosis
Role: collaborator
Brain Stimulation Enhance Post-stroke Walking Survivors and Healthy Adults
Role: collaborator
Effect of mTOR Inhibition & Other Metabolism Modulating Interventions on the Elderly [SubStudy Rapa & cMRI to Evaluate Cardiac Function]
Role: collaborator
Phenotyping Adherence Through Technology-Enabled Reports and Navigation
Role: collaborator
Intelligent Personal Assistant for Managing Depression in Homebound Older Adults
Role: collaborator
Recommendations and Alerting for Delirium Alleviation in Real-Time (RADAR)
Role: collaborator
Effect of Behavioral Lifestyle Intervention on Frailty in Older Adults With Diabetes
Role: collaborator
Feasibility of a Stroke Specific Self-management Program
Role: collaborator
Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS
Role: collaborator
Stress-Busting Program and QoL, Bio-markers of Immunity/Stress and Cellular Aging
Role: collaborator
All 12 trials loaded